Harsch Mutya 4
4 · VYNE Therapeutics Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
Transactions
- Tax Payment
Common Stock
2025-09-30$0.34/sh−3,581$1,200→ 129,484 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.